Alcista
$96.20
Precio del escenario
$84.070
-0.118 (-0.14%)Al cierre
SS&C Technologies Holdings, Inc. is a provider of services and software for the financial services and healthcare industries. Its portfolio of products and software-enabled services allows our financial services clients to automate and integrate front-office functions such as trading and modeling, middle-office functions such as portfolio management and reporting, and back-office functions such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting. The Company provides its solutions within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. It provides solutions to the healthcare industry, including pharmacy, healthcare administration and health outcomes optimization solutions. Its healthcare solutions include claims adjudication, benefit management, care management and business intelligence services.
SS&C Technologies appears to be a good buy right now due to its current price of $81.03 being below the analyst price target of $101, indicating a potential upside of 24.7%. Additionally, the forward P/E ratio of 10.6157 suggests the stock is undervalued compared to its earnings growth potential. The RSI of 70.768 indicates that the stock is nearing overbought territory, which is a cautionary sign, but the recent strong earnings performance and positive market sentiment outweigh this risk.
RBC Capital
$101
2026-08-31
RBC Capital
2026-08-31
Precio objetivo
$101
RBC Capital
$92
2026-07-24
RBC Capital
2026-07-24
Precio objetivo
$92
Jefferies
$83
2026-07-20
Jefferies
2026-07-20
Precio objetivo
$83
JPMorgan
$87
2026-07-20
JPMorgan
2026-07-20
Precio objetivo
$87
Morgan Stanley
$78
2026-04-24
Morgan Stanley
2026-04-24
Precio objetivo
$78
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

SS&C Releases 2026 PE Dealmaking Report

SS&C Releases Survey Findings on AI Implementation

SS&C Technologies to Announce Q3 2026 Financial Results

Principal Real Estate Income Fund Declares Monthly Distributions

SS&C Unveils Next-Gen AI Solutions at Annual Conference
SS&C Technologies Holdings, Inc. is a provider of services and software for the financial services and healthcare industries. Its portfolio of products and software-enabled services allows our financial services clients to automate and integrate front-office functions such as trading and modeling, middle-office functions such as portfolio management and reporting, and back-office functions such as accounting, performance measurement, reconciliation, reporting, processing and clearing, and compliance and tax reporting. The Company provides its solutions within the institutional asset and wealth management, alternative investment management, brokerage, retirement, financial advisory and financial institutions vertical markets. It provides solutions to the healthcare industry, including pharmacy, healthcare administration and health outcomes optimization solutions. Its healthcare solutions include claims adjudication, benefit management, care management and business intelligence services. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
SS&C Technologies appears to be a good buy right now due to its current price of $81.03 being below the analyst price target of $101, indicating a potential upside of 24.7%. Additionally, the forward P/E ratio of 10.6157 suggests the stock is undervalued compared to its earnings growth potential. The RSI of 70.768 indicates that the stock is nearing overbought territory, which is a cautionary sign, but the recent strong earnings performance and positive market sentiment outweigh this risk.
12 analysts cover SSNC: 11 rate it Buy, 1 Hold and 0 Sell. The average price target is 103.29.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.